Residual Reactants, Impurities and Manufacturing Conversion as Hidden Drivers of Photopolymer Hazard

Technical-grade (meth)acrylates are often treated in formulation discussions as single molecular species. Historical analytical work shows why that simplification can fail: commercial patch-test diacrylates were reported at 81–91% purity, with tripropylene glycol diacrylate containing 13% tripropylene glycol monoacrylate, while triacrylates were 82– 86% pure and the corresponding hydroxyacrylates occurred at 1–13% [1]. Clinical evidence demonstrates that an impurity can become the causal sensitizer: acrylic acid present as an impurity in an ECG electrode hydrogel was identified by HPLC and positive patch testing as the cause of allergic contact dermatitis [4]. Conversely, a systematic irritation study of residual (meth)acrylic monomers found HEA to be the most potent dermal irritant among the tested compounds, cautioning against a general assumption that free acrylic or methacrylic acid necessarily dominates irritation [6]. For VPP, the problem continues after formulation: incomplete conversion and post-processing leave extractable residual monomers, and washing and post-processing conditions can materially change their elution and biological response [9,10]. ER-92 therefore proposes a three-state qualification architecture: raw-material composition, uncured-resin/oligomer residuals, and cured-part extractables. Hazard attribution should follow compound-specific analytical evidence rather than nominal ingredient identity, acid number alone or SDS wording.